Skip to main content
Clinical Trials/JPRN-UMIN000012219
JPRN-UMIN000012219
Recruiting
未知

Analysis of efficacy and safety of antiviral therapy with simeprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantation - Simeprevir based triple therapy for posttransplant hepatitis C

Kyoto University Hospital0 sites30 target enrollmentDecember 15, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
hepatitis C after liver transplantation
Sponsor
Kyoto University Hospital
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • without abilty to understand informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials